Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to Conclude

Edward V. Loftus, Stephàne Paul, Xavier Roblin

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Journal	Clinical Gastroenterology and Hepatology
DOIs	https://doi.org/10.1016/j.cgh.2022.12.028
State	Accepted/In press - 2023

ASJC Scopus subject areas

@article{8f217d6dea2743a290cfca4e15764fc3,

title = "Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to Conclude",

author = "Loftus, {Edward V.} and Steph{\`a}ne Paul and Xavier Roblin",

year = "2023",

doi = "10.1016/j.cgh.2022.12.028",

language = "English (US)",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to Conclude

AU - Loftus, Edward V.

AU - Paul, Stephàne

AU - Roblin, Xavier

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85147887570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147887570&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2022.12.028

DO - 10.1016/j.cgh.2022.12.028

M3 - Editorial

C2 - 36610500

AN - SCOPUS:85147887570

SN - 1542-3565

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

ER -